Bantam Pharmaceuticals
Bantam Pharmaceuticals
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 1 Trial of BTM-3566 in Relapsed/Refractory Mature B Cell Lymphomas | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 | 2026-07-07 | NCT06792734 | |
| BTM-3566 in Advanced Solid Tumors | Advanced Solid Tumors | Recruiting | Phase 1 | 2025-12-17 | NCT07266285 |